Lobbying ≠ campaign money. These LDA lobbying figures are a separate, unbridged channel from FEC campaign contributions; this platform does not yet link a lobbying registrant to any FEC committee. See the methodology glossary.
SIDLEY AUSTIN LLP
Lobbying registrant · 35230
44 filings on record; a reported $530,000 in total across them. Honesty note: each amount is the registrant's reported lobbying income/spend for that quarter (a lump sum required by the Lobbying Disclosure Act, or LDA — the law governing public lobbying reports), so this total is a gross sum of quarterly figures. The filings do disclose which bills were lobbied on (below), but never how much of the money went to any one bill, and never whether the filer supported or opposed it.
Clients
- HEMOPHILIA FEDERATION OF AMERICA
- FORIS DAX, INC. D/B/A CRYPTO.COM
- ENVOY MEDICAL CORPORATION
- DUKE UNIVERSITY MEDICAL CENTER
- CRAIGSLIST, INC.
- CPI CARD GROUP
- APTIV PLC
- APEX FINTECH SOLUTIONS
- ANNEXON BIOSCIENCES
- YUM CHINA HOLDINGS, INC.
- TAYLOR FRESH FOODS, INC
- U.S. BUSINESS ALLIANCE FOR CUSTOMS MODERNIZATION
- SUNRISE MEDICAL (US) LLC
- SMALL REFINERS OF AMERICA
- OCI HOLDINGS COMPANY LTD.
- NINESTAR CORPORATION
- MASTERCARD INTERNATIONAL INCORPORATED
- KARYOPHARM THERAPEUTICS
- INTERCEPT PHARMACEUTICALS, INC.
- ALIBABA GROUP HOLDING LIMITED
- INSPUR GROUP CO. LTD.
Filings
| Client | Period | Reported quarterly amount | Filing type |
|---|---|---|---|
| HEMOPHILIA FEDERATION OF AMERICA | Q2 2026 | $10,000 | Q2 |
| FORIS DAX, INC. D/B/A CRYPTO.COM | Q2 2026 | not reported | Q2Y |
| ENVOY MEDICAL CORPORATION | Q2 2026 | not reported | Q2 |
| DUKE UNIVERSITY MEDICAL CENTER | Q2 2026 | $10,000 | Q2 |
| CRAIGSLIST, INC. | Q2 2026 | not reported | Q2Y |
| CPI CARD GROUP | Q2 2026 | not reported | Q2Y |
| APTIV PLC | Q2 2026 | not reported | Q2Y |
| APEX FINTECH SOLUTIONS | Q2 2026 | not reported | Q2Y |
| ANNEXON BIOSCIENCES | Q2 2026 | not reported | Q2Y |
| YUM CHINA HOLDINGS, INC. | Q2 2026 | not reported | Q2Y |
| TAYLOR FRESH FOODS, INC | Q2 2026 | $40,000 | Q2 |
| U.S. BUSINESS ALLIANCE FOR CUSTOMS MODERNIZATION | Q2 2026 | not reported | Q2Y |
| SUNRISE MEDICAL (US) LLC | Q2 2026 | $10,000 | Q2 |
| SMALL REFINERS OF AMERICA | Q2 2026 | $260,000 | Q2 |
| OCI HOLDINGS COMPANY LTD. | Q2 2026 | not reported | Q2Y |
| NINESTAR CORPORATION | Q2 2026 | not reported | Q2Y |
| MASTERCARD INTERNATIONAL INCORPORATED | Q2 2026 | $20,000 | Q2 |
| KARYOPHARM THERAPEUTICS | Q2 2026 | not reported | Q2 |
| INTERCEPT PHARMACEUTICALS, INC. | Q2 2026 | not reported | Q2Y |
| SMALL REFINERS OF AMERICA | Q2 2026 | not reported | RR |
| ALIBABA GROUP HOLDING LIMITED | Q1 2026 | not reported | 1TY |
| YUM CHINA HOLDINGS, INC. | Q1 2026 | not reported | Q1Y |
| U.S. BUSINESS ALLIANCE FOR CUSTOMS MODERNIZATION | Q1 2026 | not reported | Q1Y |
| SUNRISE MEDICAL (US) LLC | Q1 2026 | $10,000 | Q1 |
| OCI HOLDINGS COMPANY LTD. | Q1 2026 | not reported | Q1Y |
| NINESTAR CORPORATION | Q1 2026 | not reported | Q1Y |
| MASTERCARD INTERNATIONAL INCORPORATED | Q1 2026 | $30,000 | Q1 |
| KARYOPHARM THERAPEUTICS | Q1 2026 | not reported | Q1 |
| INTERCEPT PHARMACEUTICALS, INC. | Q1 2026 | not reported | Q1Y |
| TAYLOR FRESH FOODS, INC | Q1 2026 | $60,000 | Q1 |
| DUKE UNIVERSITY MEDICAL CENTER | Q1 2026 | $10,000 | Q1 |
| INSPUR GROUP CO. LTD. | Q1 2026 | not reported | 1TY |
| HEMOPHILIA FEDERATION OF AMERICA | Q1 2026 | $10,000 | Q1 |
| FORIS DAX, INC. D/B/A CRYPTO.COM | Q1 2026 | not reported | Q1Y |
| ENVOY MEDICAL CORPORATION | Q1 2026 | not reported | Q1Y |
| CRAIGSLIST, INC. | Q1 2026 | not reported | Q1Y |
| CPI CARD GROUP | Q1 2026 | $60,000 | Q1 |
| APTIV PLC | Q1 2026 | not reported | Q1Y |
| APEX FINTECH SOLUTIONS | Q1 2026 | not reported | Q1Y |
| ANNEXON BIOSCIENCES | Q1 2026 | not reported | Q1Y |
| ALIBABA GROUP HOLDING LIMITED | Q1 2026 | not reported | Q1Y |
| DUKE UNIVERSITY MEDICAL CENTER | Q1 2026 | not reported | RR |
| HEMOPHILIA FEDERATION OF AMERICA | Q1 2026 | not reported | RR |
| CPI CARD GROUP | Q1 2026 | not reported | RR |
Source: Senate LDA filings.
Bills lobbied on
Bills named in this registrant's filings. A titled link means the bill is in our corpus; a bare canonical reference means it is not.
- To amend the Clean Air Act with respect to the ethanol waiver for Reid Vapor Pressure under that Act, and for other purposes. (us-119-hr-1346)
- us-119-hr-1921 (not in corpus)
- Stem Cell Therapeutic and Research Reauthorization Act of 2025 (us-119-hr-5160)
- us-119-s-983 (not in corpus)
Bill references are free-text extractions from LDA specific_issues;
they show a bill was named in a quarter, not money spent on it.